| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 256 |
| 1 | VEDOLIZUMAB | 157 |
| 2 | INFLIXIMAB | 145 |
| 3 | CIPROFLOXACIN HYDROCHLORIDE | 91 |
| 4 | CIPROFLOXACIN | 89 |
| 5 | METRONIDAZOLE | 88 |
| 6 | ISOTRETINOIN | 82 |
| 7 | PREDNISONE | 65 |
| 8 | CIPROFLOXACIN TABLETS | 60 |
| 9 | CIPROFOLXACIN | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 13 | 0.0909 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 17 | 0.0688 |
| 2 | TRIPROLIDINE HCL, DEXTROMETHORPHAN HBR | 1 | 0.0556 |
| 3 | BENZHYDROCODONE AND ACETAMINOPHEN | 1 | 0.0476 |
| 4 | ADALIMUMAB-AACF | 6 | 0.0179 |
| 5 | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0143 |
| 6 | CHLORPROMAZINE HYDROCHLORIDE | 11 | 0.0115 |
| 7 | ESTRONE | 1 | 0.0093 |
| 8 | INFLIXIMAB-DYYB | 18 | 0.0052 |
| 9 | AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE | 6 | 0.0048 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 219 |
| 1 | Corticosteroid [EPC] | 165 |
| 2 | Integrin Receptor Antagonist [EPC] | 158 |
| 3 | Nitroimidazole Antimicrobial [EPC] | 89 |
| 4 | Interleukin-23 Antagonist [EPC] | 86 |
| 5 | Retinoid [EPC] | 82 |
| 6 | Aminosalicylate [EPC] | 64 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 62 |
| 8 | Vitamin C [EPC] | 47 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 1 | Integrin Receptor Antagonist [EPC] | 158 | 0.0018 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Nitroimidazole Antimicrobial [EPC] | 89 | 0.0013 |
| 4 | Provitamin D2 Compound [EPC] | 34 | 0.0011 |
| 5 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 6 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 7 | Allylamine Antifungal [EPC] | 6 | 0.0008 |
| 8 | Interleukin-23 Antagonist [EPC] | 86 | 0.0008 |
| 9 | Bile Acid [EPC] | 15 | 0.0007 |